Skip to main content
Enlyte Logo
  • Referrals
  • Pharmacy Locator
  • Find a Genex Provider
  • Find a Coventry Provider
  • Enlyte360
  • APD Solutions
  • Casualty Solutions
    • Solutions
      • Cost Containment Services
        • Medical Bill Review
          • Bill Audit
          • Electronic Payments
          • Negotiations
          • Regulatory Reporting
          • Specialty Bill Review
        • Injury & Liability
          • Bodily Injury Integrated Solutions
          • Demand Package Review
          • Injury Evaluation
          • Medical Records Summarization
      • Injury Management
        • Case Management
          • Field Case Management
          • Telephonic Case Management
          • Catastrophic Case Management/Crisis Response
          • Vocational Case Management
          • Ergonomics and Physical Demands
          • Alternative Transitional Duty
        • Medicare Set-Aside
        • Nurse Triage
        • Utilization Review
      • Network Management
        • Broad-Based Networks
        • Outcomes-Based Network
        • State-Certified Managed Care Plans
      • Pharmacy Benefit Management
        • Clinical Pharmacy Management
        • Pharmacy Intervention
      • Specialty Services
        • Diagnostics
        • Durable Medical Equipment
        • Home Health Care
        • Orthotics and Prosthetics
        • Physical Medicine
        • Translation
        • Transportation
        • Additional Services
  • Disability Solutions
    • Solutions
      • Manage Disability and Absence
        • Short-term and Long-term Disability
        • Absence Management for Payers
        • STD and ADAAA Services for Employers
      • Social Security and Disability
        • Carrier and Self Insured
        • Disabled Individuals
          • Social Security Team
          • Social Security Lookup
          • Social Security Training
        • Medicare Counseling Services
        • Ticket to Work
  • Tools
    • Solutions
      • Adjusters
        • Enlyte360
        • Locations
        • Make a Referral
        • Resource Hub
      • Clients
        • Enlyte Portal
        • Find a Provider
        • Client Specific Networks
        • Customer Reporting
        • ScriptAdvisor Resources
      • Providers
        • Apricus Provider Resources
        • Coventry Provider Resources
          • Provider Portal
      • Injured/Disabled Individuals
        • Pharmacy Locator
        • Social Security Lookup
        • My Account
  • Insights
    • CE Webinars
    • Events
    • Regulatory & Compliance
    • Trend Reports
    • More Expert Insights ›
  • About Enlyte
    • Values and Culture
    • Leadership
    • News
    • Careers
  • Home
  • Insights
  • Events
  • Webinar: The Whole Person Approach
Workers' Comp

Webinar: The Whole Person Approach

Author profile image

Tammy Bradly

Senior Director, Clinical Strategy and Market Insights

Event Details

Start: May 4, 2021 @ 2:00PM EDT End: @ Location: Online Event

Identifying social determinants of health to assist in recovery and return to work

Case managers have long known the importance of getting to know an injured employee and their family on a more intimate level. They understand that observing the “whole person,” helps to identify factors such as economic stability, home life, and access to healthy food. And they are keenly aware that these aspects of a person’s life, also known as social determinants of health, have a significant influence on recovery and return to work. During this session, we’ll focus on defining social determinants of health, the conditions in which an individual lives, works, learns and plays, and discuss how to align a care management approach to address these non-medical barriers.

Download a copy of the slides and watch the on-demand webinar below.

 

More stories

Enlyte Article

FDA Approves Combination NSAID/Opioid Seglentis

October 22, 2021

On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).

Enlyte Article

FDA Approves Combination NSAID/Opioid Seglentis

October 21, 2021

On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

PDF Article

Specialty Services Are a Big Deal

October 21, 2021

When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.

Auto Casualty Virtual Event

Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In

On-Demand

In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.

Enlyte News Release

Enlyte Family of Companies Publish Inaugural Report Offering Trends and Predictions for Property & Casualty (P&C) and Collision Repair Industries

October 19, 2021

Under its new parent brand, Mitchell, Genex and Coventry launch first edition of Enlytened, examining continuing impact of COVID-19 on innovation and technology

Enlyte News Release

Mitchell, Genex and Coventry Unite Under a Single, New Brand: Meet Enlyte

October 13, 2021

SAN DIEGO, CA—October 13, 2021—Mitchell, Genex and Coventry formally announced today the creation of their new parent brand, Enlyt

  • Load More
Enlyte Logo
  • Media
  • Careers
  • Contact Us

Mitchell

Genex

Coventry

Apricus

twitter X social media icon twitter LinkedIn social media icon twitter YouTube social media icon

©2026 Enlyte Group, LLC. All rights reserved.

Terms of Use

Privacy Practices

Minnesota Rehabilitation Services

Verisys

California Privacy Rights